BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20652713)

  • 41. Evaluation of the IDS One-Step ELISA kits for the detection of illicit drugs in hair.
    Pujol ML; Cirimele V; Tritsch PJ; Villain M; Kintz P
    Forensic Sci Int; 2007 Aug; 170(2-3):189-92. PubMed ID: 17628371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Illicit Drugs in Oral Fluid: Evaluation of Two Collection Devices.
    Cohier C; Mégarbane B; Roussel O
    J Anal Toxicol; 2017 Jan; 41(1):71-76. PubMed ID: 27681339
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The detection of THC, CBD and CBN in the oral fluid of Sativex® patients using two on-site screening tests and LC-MS/MS.
    Molnar A; Fu S; Lewis J; Allsop DJ; Copeland J
    Forensic Sci Int; 2014 May; 238():113-9. PubMed ID: 24699310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. First nationwide study on driving under the influence of drugs in Switzerland.
    Senna MC; Augsburger M; Aebi B; Briellmann TA; Donzé N; Dubugnon JL; Iten PX; Staub C; Sturm W; Sutter K
    Forensic Sci Int; 2010 May; 198(1-3):11-6. PubMed ID: 20211534
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of a rapid oral fluid point-of-care test for MDMA.
    Wilson L; Jehanli A; Hand C; Cooper G; Smith R
    J Anal Toxicol; 2007 Mar; 31(2):98-104. PubMed ID: 17536745
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of Δ(9) -tetrahydrocannabinol detection using DrugWipe5S(®) screening and oral fluid quantification after Quantisal™ collection for roadside drug detection via a controlled study with chronic cannabis users.
    Wille SM; Di Fazio V; Toennes SW; van Wel JH; Ramaekers JG; Samyn N
    Drug Test Anal; 2015 Mar; 7(3):178-86. PubMed ID: 24753449
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid.
    Cone EJ; Clarke J; Tsanaclis L
    J Anal Toxicol; 2007 Oct; 31(8):424-33. PubMed ID: 17988455
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estimating community drug abuse by wastewater analysis.
    Zuccato E; Chiabrando C; Castiglioni S; Bagnati R; Fanelli R
    Environ Health Perspect; 2008 Aug; 116(8):1027-32. PubMed ID: 18709161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. False-positive and false-negative rates in meconium drug testing.
    Moore C; Lewis D; Leikin J
    Clin Chem; 1995 Nov; 41(11):1614-6. PubMed ID: 7586551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Codeine testing in sweat and saliva with the Drugwipe.
    Kintz P; Cirimele V; Ludes B
    Int J Legal Med; 1998; 111(2):82-4. PubMed ID: 9541855
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection and prevalence of drug use in arrested drivers using the Dräger Drug Test 5000 and Affiniton DrugWipe oral fluid drug screening devices.
    Logan BK; Mohr AL; Talpins SK
    J Anal Toxicol; 2014 Sep; 38(7):444-50. PubMed ID: 24894458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Negative-ion chemical ionization gas chromatography-mass spectrometry assay for enantioselective measurement of amphetamines in oral fluid: application to a controlled study with MDMA and driving under the influence cases.
    Peters FT; Samyn N; Kraemer T; Riedel WJ; Maurer HH
    Clin Chem; 2007 Apr; 53(4):702-10. PubMed ID: 17332148
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analytical reliability of four oral fluid point-of-collection testing devices for drug detection in drivers.
    Scherer JN; Schuch JB; Rabelo-da-Ponte FD; Silvestrin R; Ornell R; Sousa T; Limberger RP; Pechansky F
    Forensic Sci Int; 2020 Oct; 315():110434. PubMed ID: 32758788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Assessing illicit drugs in wastewater: a pilot study in Mexico].
    Cruz-Cruz C; Vidaña-Pérez D; Mondragón Y Kalb M; Martínez-Ruiz MJ; Olaiz-Fernández G; Hernández-Lezama LF; Hernández-Ávila M; Barrientos-Gutiérrez T
    Salud Publica Mex; 2019; 61(4):461-469. PubMed ID: 31314209
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cocaine and benzoylecgonine oral fluid on-site screening and confirmation.
    Ellefsen KN; Concheiro M; Pirard S; Gorelick DA; Huestis MA
    Drug Test Anal; 2016; 8(3-4):296-303. PubMed ID: 26968560
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimization of cloned enzyme donor immunoassay cut-offs for drugs of abuse in post-mortem whole blood.
    Pelletti G; Rossi F; Garagnani M; Barone R; Roffi R; Fais P; Pelotti S
    Forensic Sci Int; 2020 Jul; 312():110291. PubMed ID: 32353744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
    Davey J; Leal N; Freeman J
    Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drivers under the influence of drugs of abuse: quantification of cocaine and impaired driving.
    Arroyo A; Sánchez M; Barberia E; Barbal M; Marrón MT; Mora A
    Med Leg J; 2013; 81(Pt 3):135-43. PubMed ID: 24057314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence of opiates, amphetamines, and cocaine in hair and blood in fatal cases of heroin overdose.
    Kronstrand R; Grundin R; Jonsson J
    Forensic Sci Int; 1998 Mar; 92(1):29-38. PubMed ID: 9627973
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simultaneous, quantitative determination of opiates, amphetamines, cocaine and benzoylecgonine in oral fluid by liquid chromatography quadrupole-time-of-flight mass spectrometry.
    Mortier KA; Maudens KE; Lambert WE; Clauwaert KM; Van Bocxlaer JF; Deforce DL; Van Peteghem CH; De Leenheer AP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 779(2):321-30. PubMed ID: 12361746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.